Loading
Latest filing published 12 Jun 2026 for RaySearch Laboratories AB (publ), €27k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Peter Kemlin in RaySearch Laboratories AB (publ), where the filings describe the role as senior executive. The record holds 2 filings, for trades running from 19 May 2025 to 11 June 2026.
On the open market, the record shows 1 purchase worth €27k and 1 sale worth €32k. Sales outweigh purchases by €5,033. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 1 purchase and no sales.
The newest entry dates from 12 June 2026: an open-market purchase of €27k, in RaySearch Laboratories AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations